Is your Wegovy real? Sealed-pen visible checks

Wegovy (semaglutide), manufactured by Novo Nordisk, is one of the most recognised GLP-1 weight-management pens worldwide. In India, Wegovy launched through Novo Nordisk's Indian arm in mid-2025, and demand has run well ahead of supply — which is exactly the condition under which counterfeit and diverted pens tend to appear in unofficial channels.

If you already have a Wegovy pen in hand, or are about to buy one, this page walks through the visible checks you can do on the sealed carton and pen, before injecting. These are observational red flags, not authenticity guarantees — passing every check does not prove a pen is genuine, but failing even one is a reason to pause and verify.

For a side-by-side of all GLP-1 pens sold in India and the cross-brand fake-spotting framework, see the GLP-1 counterfeit hub. For Wegovy's current Indian pharmacy prices and importer details, see the Wegovy India brand page. You can also upload a photo of your Wegovy pen and the tool will flag visible inconsistencies against Novo Nordisk's published packaging.

Red flags to look for

These are sealed-carton, pre-injection checks. Do not open or dispose of the pen if something looks wrong — the carton itself is the evidence.

• Brand-name misspellings or spacing errors. The legitimate carton prints Wegovy® with a registered-trademark mark, in Novo Nordisk's signature typeface. Counterfeit cartons commonly reported in GLP-1 seizures show variants like Wegovi, *Wegovy (no ®), WeGovy, or odd kerning between letters. Compare against Novo Nordisk's published packaging photos.
• Holographic seal and tamper-evidence. Genuine Wegovy cartons typically arrive with intact end-flap seals and no signs of re-gluing. Many people commonly report counterfeits with missing holograms, dull/photocopied holograms, or seals that have been sliced and re-stuck.
• Batch number and expiry format. Indian-market Wegovy batch/expiry is laser-printed (not ink-stamped, not stickered) in a consistent font on both the carton and the pen label. Smudged ink, mismatched batch numbers between carton and pen, or stickers pasted over original print are red flags.
• MRP printing in ₹. A legitimately imported pack sold in India will carry an MRP in ₹, the importer's name and address, and a "Manufactured by Novo Nordisk" line. A carton with only USD/EUR/AED pricing, or no MRP panel at all, suggests grey-market diversion rather than authorised Indian import.
• CDSCO import licence / importer details. Authorised Indian-market Wegovy lists the CDSCO-registered importer on the secondary carton. Absence of any Indian importer block, or a vague "imported by" line with no address, is a documented counterfeit pattern.
• Dose-strength colour coding. Wegovy's pen strengths (0.25, 0.5, 1.0, 1.7, 2.4 mg) each use a distinct colour scheme on Novo Nordisk's global artwork. Cartons where the colour looks off-shade, washed out, or where the strength on the carton does not match the pen inside are commonly reported in fake reports.
• Pen window and solution clarity. Through the pen's inspection window, the solution should appear clear and colourless per the label. Cloudiness, particles, or a yellow tint on a sealed unopened pen is a red flag.
• Carton finish and print quality. Genuine Novo Nordisk cartons have crisp, high-resolution printing with consistent font weight. Blurry text, pixelated logos, rough cardboard, or a chemical/solvent smell from the carton are commonly reported counterfeit signs.

If any one of these red flags is present, do not inject. Keep the carton, the pen, the pharmacy bill, and any outer courier packaging together — these are what a pharmacist, doctor, or CDSCO officer will need to investigate further.

What to do if something looks off

If your Wegovy pen fails one or more of the visible checks above, the calm path is:

1. Stop and do not inject. Set the pen aside in its carton.
2. Return to the pharmacist where you bought it, with the bill. Authorised pharmacies are required to trace the supply chain back to the Novo Nordisk distributor.
3. Report to CDSCO. Suspected counterfeit medicines can be reported to the Central Drugs Standard Control Organisation through their online complaint portal or your state Drug Controller.
4. Speak to your prescribing doctor before sourcing a replacement, especially if you are mid-titration — your doctor may want to adjust the schedule.

Glipin is an information tool. We surface visible red flags from photos; we do not chemically test pens and we cannot certify any pen as genuine. For any decision about whether to inject, switch brands, or change your dose, consult your doctor and your pharmacist. You can also re-check pens any time at /check.